Vol 72, No 3 (2021)
Clinical vignette
Published online: 2021-06-30
Increased efficacy of hypothyroidism control with liquid levothyroxine [Większa skuteczność lewotyroksyny w postaci płynnej w wyrównywaniu niedoczynności tarczycy]
Abstract
Not required for Clinical Vignette.
Keywords: hypothyroidismliquid levothyroxineTirosint SOL
References
- Okosieme OE, Belludi G, Spittle K, et al. Adequacy of thyroid hormone replacement in a general population. QJM. 2011; 104(5): 395–401.
- Ruchała M, Szczepanek-Parulska E, Zybek A. The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. Endokrynol Pol. 2012; 63(4): 318–323.
- Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012; 62(12): 631–636.
- Fallahi P, Ferrari SM, Antonelli A. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study. Endocrine. 2016; 52(3): 597–601.
- Gietka-Czernel M, Hubalewska-Dydejczyk A, Kos-Kudła B, et al. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy]. Endokrynol Pol. 2020; 71(5): 441–465.